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Background: The occurrence of asthma is weakly explained by known genetic variants. Epigenetic marks, DNA
methylation (DNA-M) in particular, are considered to add to the explanation of asthma. However, no etiological
model has yet been developed that integrates genetic variants and DNA-M. To explore a new model, we focused
on one asthma candidate gene, the IL-4 receptor (IL4R). We hypothesized that genetic variants of IL4R in interaction
with DNA-M at cytosine-phosphate-guanine (CpG) sites jointly alter the risk of asthma during adolescence. Blood
samples were collected at age 18 years from 245 female cohort participants randomly selected for methylation
analysis from a birth cohort (n = 1,456, Isle of Wight, UK). Genome-wide DNA-M was assessed using the Illumina
Infinium HumanMethylation450 BeadChip.
Results: Thirteen single nucleotide polymorphisms (SNPs) and twelve CpG sites of IL4R gene were analyzed. Based
on linkage disequilibrium and association with asthma, eight SNPs and one CpG site were selected for further
analyses. Of the twelve CpG sites in the IL4R gene, only methylation levels of cg09791102 showed an association
with asthma at age 18 years (Wilcoxon test: P = 0.01). Log-linear models were used to estimate risk ratios (RRs) for
asthma adjusting for uncorrelated SNPs within the IL4R gene and covariates. Testing for interaction between the
eight SNPs and the methylation levels of cg09791102 on the risk for asthma at age 18 years, we identified the
statistically significant interaction term of SNP rs3024685 × methylation levels of cg09791102 (P = 0.002; after
adjusting for false discovery rate). A total of 84 participants had methylation levels ≤0.88, 112 participants between
0.89 and 0.90, and 35 between 0.91 and 0.92. For the SNP rs3024685 (‘CC’ vs. ‘TT’) at methylation levels of ≤0.85,
0.86, 0.90, 0.91, and 0.92, the RRs were 0.01, 0.04, 4.65, 14.76, 14.90, respectively (interaction effect, P = 0.0003).
Conclusions: Adjusting for multiple testing, our results suggest that DNA-M modulates the risk of asthma related
to genetic variants in the IL4R gene. The strong interaction of one SNP and DNA-M is encouraging and provides a
novel model of how a joint effect of genetic variants and DNA-M can explain occurrence of asthma.
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Asthma is a common chronic disease that affects around
235 million people around the world and 5.4 million in
the United Kingdom (UK) [1]. The burden of disease
affects 1.1 million children between ages 0 to 17 years in
the UK. Asthma is characterized clinically by shortness* Correspondence: KARMAUS@mailbox.sc.edu
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distribution, and reproduction in any mediumof breath, wheezing episodes, chest tightness, and acute
episodes of coughing [2]. The disease etiology is poorly
understood and the postnatal development is not well
established. Genetic susceptibility, environmental fac-
tors, and gene × environment interaction are believed to
play a critical role in the development of asthma. Over
200 genes have been suggested to contribute to asthma
occurrence [3-5]. The high heritability (35% to 95%) and
the co-occurrence of asthma within families highlight
the importance of a genetic component in diseaseentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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kin receptor (IL4R) gene which has been clearly estab-
lished as an asthma susceptibility gene in multiple
candidate gene association studies [3-5].
There is evidence that interleukin-4 (IL-4) and its re-
ceptor (IL-4R) are involved in the pathogenesis of
asthma [6-8]. A recent meta-analysis indicated a modest
risk associated with IL4R single nucleotide polymorph-
isms (SNPs) on occurrence of asthma, but other investi-
gators found conflicting results [7]. Analysis of asthma
candidate genes in a genome-wide association study
population showed that SNPs in IL4R were significant
related to asthma with significance level between P = 0.05
and P = 0.0035 [3] despite IL4R not being identified in
genome-wide association study (GWAS) analysis suggest-
ing that IL4R variation is not well captured in current
GWAS platforms. Other genetic regulatory mechanisms
beyond DNA sequence variation may aid in explaining the
role of IL4R in asthma. It has been suggested that epigen-
etic mechanisms play a role in T-cell differentiation and
regulation, a crucial event in the onset of atopic diseases
such as asthma [9]. Epigenetic regulatory mechanisms,
such as DNA-methylation (DNA-M), may alter gene ex-
pression and protein production without changing the
DNA sequence. No etiological model has yet been devel-
oped that integrates genetic variants and DNA-M. We will
explore the idea that an increase of DNA-M may silence
or a decrease of DNA-M may activate the effect of specific
SNPs. To test this new model, we focus on one asthma
candidate gene, the IL4R gene. We hypothesized that
SNPs in interaction with cytosine-phosphate-guanine
(CpG) sites jointly predispose to asthma at age 18 years.
To test vertical transmission of DNA-M to offspring in fu-
ture steps, this work focuses on women.
Methods
Study design and population
A whole-population birth cohort was established on the
Isle of Wight in 1989 to prospectively study the natural
history of asthma and allergic conditions. After exclusion
of adoptions, perinatal deaths and refusal, 1,456 children
(95%) were enrolled. The local research ethics commit-
tee approved the study and informed written parental
consent was obtained for all participants at recruitment
and subsequently at follow-ups, which were conducted
at ages 1, 2, 4, 10, and 18 years of age. The birth cohort
has been described in detail elsewhere [10,11]. In this
study we focused on blood samples collected at 18 years
of age from 245 female cohort participants who were
randomly selected for genomic sequencing and DNA-M.
Clinical data collection and outcome
Maternal history of asthma and smoking during preg-
nancy was ascertained at birth. Birth weight was obtainedfrom birth records. At ages 1, 2, 4, 10, and 18 years, the
original questionnaire-based information was updated,
and weight and height of the child were measured. Breast-
feeding duration was assessed at follow-up visits at ages 1
and 2 years. At age 18 years, the questionnaire-based
information was updated using the International Study of
Asthma and Allergies in Childhood (ISAAC) question-
naire [12]. Asthma at age 18 years was defined as subjects
with a physician diagnosis of asthma plus current symp-
toms and/or asthma medication.SNP selection for the IL4R gene
An efficient genotype tagging scheme was developed
that gave priority to variants that 1) showed strong asso-
ciation with asthma in the Isle of Wight birth cohort,
and/or 2) have been reported by others to be associated
with asthma/allergy, and/or 3) have functional import-
ance. A literature search for IL4R gene plus asthma and
allergy was used to identify associated variants (SNPs,
indels). Functional variants included those that were
non-synonymous, located in conserved DNA, and/or
present in DNA regions with gene regulatory potential.
Tagger implemented in Haploview 3.2 using Caucasian
Hapmap data was used to develop a tagging scheme for
the IL4R gene region, including 10 kb upstream and
downstream of the gene [13]. An r2 value of 0.85 was
the threshold for tagging and one, two and three SNP
marker combination tests were used. The result was an
efficient number of genotyped variants (n = 13) that
would provide the needed information to statistically
support or exclude the gene in its association with
asthma outcomes.DNA methylation protocol
DNA was extracted from whole blood using a standard
salting out procedure [14]. DNA concentration was
determined by PicoGreen quantitation. One microgram
DNA was bisulfite-treated for cytosine to thymine con-
version using the EZ 96-DNA methylation kit (Zymo Re-
search, Irvine, CA, USA), following the manufacturer’s
standard protocol. Genome-wide DNA methylation was
assessed using the Illumina Infinium HumanMethyla-
tion450 BeadChip (Illumina, Inc., San Diego, CA, USA),
which interrogates >484,000 CpG sites associated with
approximately 24,000 genes. Arrays were processed
using a standard protocol as described elsewhere [15],
with multiple identical control samples assigned to each
bisulphite conversion batch to assess assay variability
and samples randomly distributed on microarrays to
control against batch effects. The BeadChips were
scanned using a BeadStation, and the methylation level
(beta value) calculated for each queried CpG locus using
the Methylation Module of BeadStudio software.
Table 1 Location, position, and distance between the SNPs and the CpG sites in the IL4R gene
CpG sites
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SNPs Location# 27324341 27324953 27325000 27325237 27325254 27325672 27326054 27338391 27345891 27353414 27367172 27375732
rs2057768
50UTR 27322095 −2246 −2858 −2905 −3142 −3159 −3577 −3959 −16296 −23796 −31319 −45077 −53637
rs6498012
Intron 27331974 7633 7021 6974 6737 6720 6302 5920 −6417 −13917 −21440 −35198 −43758
rs3024622
Intron 27365453 41112 40500 40453 40216 40199 39781 39399 27062 19562 12039 −1719 −10279
rs4787423
Intron 27367334 42993 42381 42334 42097 42080 41662 41280 28943 21443 13920 162 −8398
rs3024676
Coding 27373558 49217 48605 48558 48321 48304 47886 47504 35167 27667 20144 6386 −2174
rs3024685
30UTR 27376910 52569 51957 51910 51673 51656 51238 50856 38519 31019 23496 9738 1178
rs12102586
30UTR 27378053 53712 53100 53053 52816 52799 52381 51999 39662 32162 24639 10881 2321
rs16976728
30UTR 27381712 57371 56759 56712 56475 56458 56040 55658 43321 35821 28298 14540 5980
#The location is based on Build 37, also known as GRCh37. The distance was calculated by subtracting the location of the SNP to the CpG site in the IL4R gene. For instance, the distance between the SNP rs6498012
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The main exposures are SNPs and the methylation levels
at CpG sites in the IL4R gene (Table 1). The following
SNPs were included in the analysis: rs3024622, rs3024685,
rs6498012, rs12102586, rs16976728, rs4787423, rs3024676,
and rs2057768.
Statistical analysis
To assess whether our analytic sample (245 DNA sam-
ples) was representative of the total cohort available at age
18 years, we compared the characteristics of these two
subsets by using the chi-square test. After cleaning the
DNA-M data, beta (β) values presented as the proportion
of intensity of methylated (M) over the sum of methylated
(M) and unmethylated (U) sites (β = M/[c + M + U] with
c being a constant to prevent dividing by zero) were used
to estimate the effect of DNA methylation [16]. The
methylation levels of 12 CpG sites spanning the genomic
region of the IL4R gene (Table 1) were tested for associ-
ation with asthma at age 18 years using Wilcoxon tests.
Of these CpG sites, only methylation levels of cg09791102
showed a statistically significant association with asthma
at age 18 years (Wilcoxon test: P = 0.01).
The 13 SNPs shown in Figure 1 were tested for
Hardy-Weinberg equilibrium using Haploview 3.2 soft-
ware [13] and estimates of linkage disequilibrium (LD)
between SNPs were calculated using D’ and r2 [17], toFigure 1 IL4R LD plot; standard (D’/LOD) color scheme; D’ LD values dselect one SNP that represents each LD block or an
unlinked area.
After identifying eight uncorrelated IL4R SNPs
(Figure 1; Table 1) and identifying which CpG site was
significantly associated with asthma, we ran eight inde-
pendent models to estimate statistical interactions
between these SNPs and the methylation level of
cg09791102 on the risk for asthma at age 18 years. We
assessed the interaction on a multiplicative scale in log-
linear models using an overall chi-square test as a cutoff
P value = 0.05 for each. Only one interaction (SNP
rs3024685 × cg09791102) showed a significant effect on
asthma at age 18. This interaction and those SNPs and
four covariates that confounded the association between
the SNP and CpG interaction with asthma at age 18
years were included in the final log-linear model. We
then inspected which genotype (CC, CT, or TT) explains
the overall effect. Confounders include child’s BMI at
age 18 (kg/m2), maternal history of asthma, maternal
smoking during pregnancy, and breastfeeding duration
(weeks). All confounders were simultaneously entered as
indicator variables into the log-linear model. A backward
elimination process was used to identify confounders,
those that changed the association of interest by 10% or
more were retained in the final model. For the reduced
model, we estimated risk ratios (RR) and their 95% con-
fidence intervals (CI).isplayed.
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tion interactions before selecting the full model, we
adjusted for multiple testing by applying false discovery
rate (P = 0.05) [18]. All statistical analyses were per-
formed using the SAS statistical package, Version 9.2
(SAS Institute, Cary, NC, USA), except for cleaning the
DNA methylation data, which was done using R statis-
tical computing package [19].
Results
Blood samples from a subset of 245 of 750 female birth
cohort participants were used to determine DNA-M at
CpG sites. There were no substantial differences in
prevalence of low birth weight, asthma at 18, BMI at 18,
breastfeeding duration, maternal BMI, maternal history
of asthma, nor maternal smoking between the female
participants of the cohort and the subset included in this
analysis (Table 2). For the subgroup with available
methylation data 12% had maternal history of asthma,
19% had mothers that smoked during pregnancy, and
14.3% (35/245) had asthma at age 18 years.Table 2 Subject characteristics with available methylation da
Total female participants n
Factors n = 750








Maternal body mass index (kg/m2)
Underweight (<18.5) 10 (1.7)
Normal (18.5- <25) 355 (61.5)










Median (5%, 95% value); n
Breastfeeding duration (weeks) 8.0 (0, 40); 664
Missing 86
Body mass index at age 18 (kg/m2) 22.2 (18, 32); 499
Missing 251Of the thirteen SNPs genotyped in the IL4R gene,
eight SNPs were analyzed since they were uncorrelated
(D’ <0.95) (Figure 1, Table 1). A total of 12 CpG sites span-
ning the genomic region of the IL4R gene were analyzed
for association with asthma at age 18 years. Only methyla-
tion levels of cg09791102 showed an association with
asthma at age 18 years (Wilcoxon test: P = 0.01). Testing
for interaction between the eight SNPs and the methyla-
tion levels of cg09791102 on the risk for asthma at age 18
years, we identified that the interaction term of SNP
rs3024685 × methylation levels of cg09791102 was statisti-
cally significant (P = 0.0003; FDR adjusted P value = 0.002;
Table 3). In other words, the genetic risk of asthma asso-
ciated with rs3024685 increases as the methylation level of
cg09791102 rises (Figure 2).
The DNA-M level range for cg09791102 was 0.48 to
0.92 (blue bars in Figure 2). Since the number of partici-
pants at methylation levels of 0.85 or less were low, we
grouped these methylation levels into ≤0.85 (n = 9). For
descriptive purposes, 84 participants had methylation
levels of 0.88 and less, 112 participants of 0.89 to 0.90, andta compared to the female participants of the total cohort


















10.5 (0, 40); 222 0.16
20
22.9 (19.05, 32.93); 240 0.56
5
Table 3 Adjusted log-linear regression model of the interaction of genetic variants and DNA methylation of the IL4R
gene on asthma at age 18 years
Parameter Estimate 95% CI P value
Intercept 19.59 −12.78 51.97 0.25
cg09791102 −26.97 −63.62 9.67 0.14
rs3024685 CC −102.45 −158.51 −46.40 0.0003
CT −38.48 −80.71 3.75 0.07
TT Reference
cg09791102* rs3024685 CC 115.54 53.18 177.91 0.0003
CT 43.90 −3.45 91.27 0.06
TT Reference
rs3024622 CC −1.24 −3.45 0.95 0.26
CG −0.14 −1.00 0.72 0.74
GG Reference
rs12102586 TT 2.41 0.29 4.53 0.02
CT 0.65 −0.24 1.55 0.15
CC Reference
rs16976728 TT −0.53 −2.03 0.95 0.48
CT 0.16 −0.78 1.11 0.72
CC Reference
Maternal smoking during pregnancy 0.43 −0.40 1.26 0.31
Maternal history of asthma 0.53 −0.41 1.49 0.26
Body mass index at age 18 years (kg/m2) 0.05 −0.009 0.12 0.09
Breastfeeding duration (weeks) 0.02 −0.004 0.04 0.11
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tive, we compared participants who had the ‘CC’ and ‘CT’
genotypes with those who were ‘TT’ genotype at
rs3024685. For the genotype ‘CC’, compared to ‘TT’, we
found that at methylation levels of 0.85, 0.86, 0.90, 0.91,≤
Figure 2 Risk Ratio of asthma at age 18 years versus
methylation score at different genotypes of IL4Rrs3024685. The
blue bars present the relative frequency of the DNA methylation
levels. For instance, 87% methylation is found in 10% of the
participants. The reference genotype is ‘TT’. The solid horizontal line
that indicates a risk ratio value of ‘1’ shows the risk ratio of the
reference ‘TT’ genotype. The black dot represents the ‘CC’ genotype,
and the diamond is ‘CT’ genotype.and 0.92, the RRs of asthma were 0.01, 0.04, 4.65, 14.76,
and 46.90 (Figure 2; FDR adjusted P value = 0.002),
respectively. Similar results were found with ‘CT’ geno-
type, however the interaction term did not achieve statis-
tical significance (P = 0.06).
Descriptively, 13.2% and 14.3% of the participants had
asthma at a methylation level of 0.88 at the genotype ‘CT’
and ‘TT’, respectively; and none of the ‘CC’ genotype had
asthma. Between 0.89 and 0.90 methylation levels, 15.0%
of the ‘CC’, 16.7% of the ‘CT’, and 7.9% of the ‘TT’ geno-
type had asthma. At methylation levels larger than 0.90,
54.6% of the ‘CC’ and 16.7% of the ‘CT’ genotype had
asthma, and none of the ‘TT’ genotype had asthma.Discussion
This is the first study to determine the role of both gen-
etic and epigenetic factors within the genomic region of
the IL4R gene on the risk for asthma. Although the CpG
site cg09791102 is located 23,496 base pairs away from
SNP rs3024685 in the intragenic region of the IL4R
gene, we found that the risk of asthma is modulated by
this CpG site even after adjusting for multiple testing.
The distance between the SNP and the CpG sites is
large. However, Bell et al. have demonstrated that for a
regulation in cis even larger distances can show statisti-
cally significant effects [20]. Hence, these two factors
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pression or alternative splicing.
The SNP rs3024685 in the 30UTR region has no inde-
pendent effect on asthma at age 18 years; however in
interaction with the CpG site cg09791102 (gene body,
Table 1) it is strongly associated with asthma in female
participants. At 92% methylation level, rs3024685 (‘CC’
genotype compared to ‘TT’) showed a 46.9-fold increase
risk for asthma. Our observation of a role of gene-body
methylation is further supported by the emerging evi-
dence, which shows that methylation in intragenic
regions can be positively correlated with gene expression
levels and phenotype variation [21,22]. Intragenic DNA
methylation has been linked to ‘exon definition’ through
interaction with auxiliary proteins, by which DNA
methylation in the body may result in alternative pre-
mRNA splicing regulation (for example, inclusion or ex-
clusion of exons) [23-25]. We assume that a higher
DNA-M may mask an otherwise protective effect of
rs3024685 and thus increases the risk of asthma [26].
Our results indicate that considering both genetic var-
iants and DNA methylation will significantly improve
the explanation of asthma. Replication of these findings
in an independent study population is needed to validate
the interplay of DNA methylation with genetic poly-
morphism, which results in an increased asthma risk.
However, currently there are only few studies that can
provide both genetic and DNA methylation data.
A limitation of our study is that the RRs at methyla-
tion levels larger than 90% are high, which is due to the
limited number of individuals (n = 36) with methylation
levels larger than 90%. Evidence of selection bias is ab-
sent since prevalence of asthma and IL4R SNPs is com-
parable between those analyzed in this study and those
from the original cohort. Multiple testing was a concern
since we tested the joint effect of differential DNA
methylation of cg09791102 and eight IL4R SNPs separ-
ately (a total of eight tests). Nevertheless, the observed
increased risk remained statistically significant after pen-
alizing its P value for false discovery rate. Regarding reli-
ability and specificity of methylation status of CpG sites, a
recent report demonstrated that the Infinium Human-
Methylation450 array, which was used to obtained DNA
methylation profiles in this study, had strong reproducibil-
ity and high validity [27]. The extent to which DNA
methylation measured in blood relate to other tissues and
whether can be used as a biomarker for phenotype
variation is unclear and is an area of current scientific
dispute [28-30].
Conclusions
The strong interaction of one SNP and DNA-M is en-
couraging and provides a novel model how a joint effect
of genetic variants and DNA-M can explain asthma.Although the sample size is limited and focused on fe-
male participants, our results should generally motivate
other studies to replicate the interaction we found, while
also searching for new interactions between genetic var-
iants and DNA methylation, in particular for the IL4R
gene and asthma.
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